Relacorilant, an oral treatment being developed by Corcept Therapeutics, appears to be safe and effective for controlling high…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
In Cushing’s disease, an imaging technique that uses a radioactive tracer targeting the CXCR4 protein may help locate the…
Isturisa (osilodrostat) is now available in Canada for adults with Cushing’s disease who have persistent or recurrent high…
Although acinic cell carcinoma — a cancer of the glands that produce saliva — is usually considered low risk,…
Persistent symptoms during corticosteroid tapering should prompt evaluation for an internal source of excess cortisol — usually from the adrenal…
A woman with Cushing’s disease developed overlapping heart symptoms, a case researchers said highlights the need for early diagnosis…
The case of a young adolescent boy illustrates that doctors should carefully taper corticosteroids and regularly monitor hormones in children…
A woman in the U.K. with Cushing’s disease was successfully treated with Isturisa (osilodrostat), which helped lower her…
Care practices at a hospital in Taiwan align with those recommended by the Pituitary Society for patients with pituitary tumors,…
Prolonged use of high-dose corticosteroid nasal sprays can lead to Cushing’s syndrome in children, according…